📌 Vijay Kedia Bets on a ₹24 Penny Stock — Revival Story in the Making?

Ace investor Vijay Kedia has picked up a stake in Mangalam Drugs at around ₹24 per share, signalling confidence in the company’s revival despite an almost 80% fall from its peak. The micro-cap pharmaceutical firm, currently battling losses and declining revenues, continues to hold strong asset value and core API manufacturing expertise. Kedia’s well-known SMILE investment philosophy focuses on spotting hidden value in underappreciated businesses — and Mangalam Drugs appears to be his latest contrarian pick. #VijayKedia #PennyStock #HiddenValue #PharmaStocks #SmallcapStocks #StockMarketIndia #ValueInvesting #StockYard